Rolapitant Reduces Nausea, Vomiting From Chemotherapy In Phase III Trial
Saturday, September 27, 2014 - 09:40
in Health & Medicine
Rolapitant reduces nausea and vomiting in patients receiving cisplatin-based chemotherapy, according to the results of a phase III trial presented for the first time today at the ESMO 2014 Congress in Madrid, Spain. read more